News About: Pharm. Industry
Ethics management seminar to be held
A local seminar will be held on February 12 at Sofitel Ambassador Hetel in Seoul with participants from the government and pharmaceutical circles.
The seminar, jointly organized by theKorea Pharmaceutcal Manufactur...
Huons ties up with Alcon Korea
Huons Co. has clinched a strategic alliance with Alcon Korea as part of its efforts to tap the global market, with its new preservative-free artificial tears eye product, KYNEX.
Under the recently executed agreemen...
Plavix generic makers agonize over market entry
Korea's 17 generic makers won the right to market Plavix (clopidogrel bisulfate) in a recent patent lawsuit, several drug makers who will join the lucrative market with their newly modified medicines are keen on the l...
Ginkgo biloba preparations to be non-reimbursable
The government says that from May, medicines containing gingko biloba will be deleted from the national health insurance list, after a two-month grace period, according to the Ministry of Health and Welfare.
Under ...
Yungjin launches Servier's new antihypertensive agent
Yungjin Pharm says it has introduced Acertil Plus tablets to strengthen its presence in the domestic hypertension market.
Developed by France based Servier Co., Acertil Plus is an antihypertensive therapy involving...
Korea's pharmaceutical exports record $1.44 billion in 2007
Korea's drug exports gained 11.5 percent from a year earlier to $1.44 billion in 2007 thanks mainly to strong shipments of finished pharmaceuticals, pharmaceutical bulks, oriental medicines and cosmetics, a local ...
Samil launches Zyrtec PlusSamil Pharm said it has launched Zyrtec Plus tablets, another brand name of UCB Korea's product, for the treatment of allergic rhinitis.
Zyrtec contains cetirizine HCl and ps...
|
Cipla Korea eyes bigger role in pharmaceutical market
Cipla Korea, an India based Korean unit and leading generic maker worldwide, is making it clear that it wants to support the domestic pharmaceutical market as a supplier of its products.
The local pharmaceutical in...
Novartis Korea, Handok sign Galvus co-promotion dealNovartis Korea and Handok Pharm entered into an agreement on January 28 for the co-promotion of Galvus (vildagliptin) to treat a wide range of patients with type 2 diabetes, a p...
|
Small-package drugs headache for drug makers
Recently, many pharmaceutical firms have found it difficult to deal with ever-increasing medicine stocks in small bundles.
Under the current regulation, drug makers are obliged to produce small-package drugs at lea...
